PharmaTher Holdings Ltd. PHRRF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 87.40K | 113.70K | 131.50K | 123.70K | 197.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.20K | 126.20K | 144.10K | 233.60K | 374.80K |
| Operating Income | -60.20K | -126.20K | -144.10K | -233.60K | -374.80K |
| Income Before Tax | 57.90K | -1.70K | -178.00K | -320.20K | -290.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.90K | -1.70K | -178.00K | -320.20K | -290.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.90K | -1.70K | -178.00K | -320.20K | -290.70K |
| EBIT | -60.20K | -126.20K | -144.10K | -233.60K | -374.80K |
| EBITDA | -- | -- | -- | -- | -374.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 91.34M | 91.02M | 91.02M | 90.92M | 88.52M |
| Average Diluted Shares Outstanding | 91.34M | 91.02M | 91.02M | 90.92M | 88.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |